What is the address of Docteur Etolo, Médecine Aiguë?

The registered office of Docteur Etolo, Médecine Aiguë is located at Louizalaan 65 box 11, 1050 Brussel.

Is Docteur Etolo, Médecine Aiguë still active?

Yes. According to the CBE (3 October 2026) Docteur Etolo, Médecine Aiguë is active, legal situation “Normale toestand”, started on 8 June 2015.

Is Docteur Etolo, Médecine Aiguë registered on Peppol?

Yes, Docteur Etolo, Médecine Aiguë is registered on the Peppol network with ID 0208:0631822168.

What is the enterprise number of Docteur Etolo, Médecine Aiguë?

The enterprise number of Docteur Etolo, Médecine Aiguë is BE0631822168.

When was Docteur Etolo, Médecine Aiguë founded?

Docteur Etolo, Médecine Aiguë was founded on 8 June 2015.

Who are the directors of Docteur Etolo, Médecine Aiguë?

According to the 2024 annual accounts, the directors of Docteur Etolo, Médecine Aiguë are: François ETOLO.

Is Docteur Etolo, Médecine Aiguë a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 8 June 2015; 4 annual accounts filed, latest fiscal year 2024; 1 directors known from the annual account.

How much profit did Docteur Etolo, Médecine Aiguë make in 2024?

Docteur Etolo, Médecine Aiguë posted a profit after taxes of € 72,776 in financial year 2024.

What is the revenue of Docteur Etolo, Médecine Aiguë?

As a small company, Docteur Etolo, Médecine Aiguë is not required to publish revenue in its annual accounts. In financial year 2024, its added value was € 130,355.

Docteur Etolo, Médecine Aiguë (Private Limited) - Brussel

Dossier Docteur Etolo, Médecine Aiguë, printed on 3 October 2026 from databakkes.be/en/0631822168/docteur-etolo-medecine-aigue. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 26 % of short-term debt in 2024; threshold 65 %.
Late annual account NBB

Fiscal year 2024 was filed 251 days after the legal deadline.

Financials

Financial year 2024

Docteur Etolo, Médecine Aiguë from Brussel, company number BE0631822168, closed financial year 2024 with a result of € 72,776 after tax. For that financial year Docteur Etolo, Médecine Aiguë recorded a gross margin of € 130,355 and equity of € 602,868. Compared with financial year 2023, the result moved from € 78,285 to € 72,776. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on April 8, 2026.

What it is worth Growing

€ 602,868

▲ 14% vs 2023

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 72,776

▼ 7% vs 2023

Profit after tax over the fiscal year.

Cash in the bank

€ 5,257

▼ 71% vs 2023

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2024. Retained profit grew to € 590,368.

People and assets in 2024

Vehicles and equipment

€ 56,890

▲ € 56,338 vs 2023

Book value of vehicles, furniture and equipment.

Debts at end 2024

Bank debt ≈ 6 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 407,728

▲ 11% vs 2023

€ 69,229 is repaid this year. At this pace the long-term loan is gone in ≈ 6 years.

Taxes

€ 66,275

▼ 7% vs 2023

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2021	2022	2023	2024	Change 2023 → 2024
Gross margin	€ 115,891 Gross margin 2021: € 115,891 First fiscal year in the series	€ 128,084 Gross margin 2022: € 128,084 ▲ 11% vs 2021 (€ 115,891) Favourable step	€ 122,938 Gross margin 2023: € 122,938 ▼ 4% vs 2022 (€ 128,084) Unfavourable step	€ 130,355 Gross margin 2024: € 130,355 ▲ 6% vs 2023 (€ 122,938) Favourable step	▲ 6%
Profit after taxes	€ 60,544 Profit after taxes 2021: € 60,544 First fiscal year in the series	€ 72,305 Profit after taxes 2022: € 72,305 ▲ 19% vs 2021 (€ 60,544) Favourable step	€ 78,285 Profit after taxes 2023: € 78,285 ▲ 8% vs 2022 (€ 72,305) Favourable step	€ 72,776 Profit after taxes 2024: € 72,776 ▼ 7% vs 2023 (€ 78,285) Unfavourable step	▼ 7%
Equity	€ 379,502 Equity 2021: € 379,502 First fiscal year in the series	€ 451,807 Equity 2022: € 451,807 ▲ 19% vs 2021 (€ 379,502) Favourable step	€ 530,092 Equity 2023: € 530,092 ▲ 17% vs 2022 (€ 451,807) Favourable step	€ 602,868 Equity 2024: € 602,868 ▲ 14% vs 2023 (€ 530,092) Favourable step	▲ 14%
Total debts	€ 472,389 Total debts 2021: € 472,389 First fiscal year in the series	€ 415,828 Total debts 2022: € 415,828 ▼ 12% vs 2021 (€ 472,389) Favourable step	€ 438,227 Total debts 2023: € 438,227 ▲ 5% vs 2022 (€ 415,828) Unfavourable step	€ 474,003 Total debts 2024: € 474,003 ▲ 8% vs 2023 (€ 438,227) Unfavourable step	▲ 8%
Cash	-	€ 857 Cash 2022: € 857 First fiscal year in the series	€ 17,994 Cash 2023: € 17,994 ▲ € 17,137 vs 2022 (€ 857) Favourable step	€ 5,257 Cash 2024: € 5,257 ▼ 71% vs 2023 (€ 17,994) Unfavourable step	▼ 71%
Land & buildings	€ 444,714 Land & buildings 2021: € 444,714 First fiscal year in the series	€ 439,950 Land & buildings 2022: € 439,950 ▼ 1% vs 2021 (€ 444,714) Unchanged	€ 427,350 Land & buildings 2023: € 427,350 ▼ 3% vs 2022 (€ 439,950) Unchanged	€ 414,750 Land & buildings 2024: € 414,750 ▼ 3% vs 2023 (€ 427,350) Unchanged	▼ 3%
Retained profit	€ 367,002 Retained profit 2021: € 367,002 First fiscal year in the series	€ 439,307 Retained profit 2022: € 439,307 ▲ 20% vs 2021 (€ 367,002) Favourable step	€ 517,592 Retained profit 2023: € 517,592 ▲ 18% vs 2022 (€ 439,307) Favourable step	€ 590,368 Retained profit 2024: € 590,368 ▲ 14% vs 2023 (€ 517,592) Favourable step	▲ 14%
Bank debt	€ 407,592 Bank debt 2021: € 407,592 First fiscal year in the series	€ 380,162 Bank debt 2022: € 380,162 ▼ 7% vs 2021 (€ 407,592) Favourable step	€ 367,021 Bank debt 2023: € 367,021 ▼ 3% vs 2022 (€ 380,162) Favourable step	€ 407,728 Bank debt 2024: € 407,728 ▲ 11% vs 2023 (€ 367,021) Unfavourable step	▲ 11%
Balance sheet total	€ 851,890 Balance sheet total 2021: € 851,890 First fiscal year in the series	€ 867,635 Balance sheet total 2022: € 867,635 ▲ 2% vs 2021 (€ 851,890) Unchanged	€ 968,319 Balance sheet total 2023: € 968,319 ▲ 12% vs 2022 (€ 867,635) Unchanged	€ 1,076,871 Balance sheet total 2024: € 1,076,871 ▲ 11% vs 2023 (€ 968,319) Unchanged	▲ 11%

Key figures of Docteur Etolo, Médecine Aiguë, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.

What happened to Docteur Etolo, Médecine Aiguë?

What happened at Docteur Etolo, Médecine Aiguë in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Apr 8, 2026 New annual accounts for financial year 2024: profit of € 72,776 (▼ 7% vs 2023). filed late Source: NBB ↗
Jun 8, 2015 Start of the company according to the CBE. KBO
2015 François ETOLO became a director. NBB

In short

From € 60,544 profit in 2021 to € 72,776 profit in 2024.

Paid € 132,458 in corporate taxes since 2021.

Best year ever: 2023, with € 78,285 profit.

Original PDFs at the National Bank ↗

A new publication or filing at Docteur Etolo, Médecine Aiguë? We notify you, reason included.

Follow Docteur Etolo, Médecine Aiguë

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

François ETOLO

Docteur Etolo, Médecine Aiguë

Behind Docteur Etolo, Médecine Aiguë is François ETOLO.

See the full network in the app

Directors

According to the 2024 annual accounts

François ETOLO

Director

since 2015

Establishments

Establishment units

Physical locations of this company

Registered office

Louizalaan 65 box 11

1050 Brussel

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0631.822.168
VAT number: BE 0631.822.168
Registered office: Louizalaan 65 bus 11, 1050 Brussel
Names & denominations: Docteur Etolo, Médecine Aiguë
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 8 June 2015
Peppol: Active · Active since 10 Mar 2026

View on CBE Public ↗ Annual accounts (NBB) ↗